Medrad Stellant CT Injection System

SOL #: 36C24226Q0453Combined Synopsis/Solicitation

Overview

Buyer

Veterans Affairs
Veterans Affairs, Department Of
242-NETWORK CONTRACT OFFICE 02 (36C242)
ALBANY, NY, 12208, United States

Place of Performance

NY

NAICS

Irradiation Apparatus Manufacturing (334517)

PSC

Medical And Surgical Instruments, Equipment, And Supplies (6515)

Set Aside

Service-Disabled Veteran-Owned Small Business (SDVOSB) Set-Aside (FAR 19.14) (SDVOSBC)

Timeline

1
Posted
Mar 20, 2026
2
Submission Deadline
Mar 26, 2026, 2:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Department of Veterans Affairs (VA), specifically NETWORK CONTRACT OFFICE 02 (36C242), has issued a Combined Synopsis/Solicitation for the purchase of a Medrad® Stellant® Flex® OCS CT Injection System. This Service-Disabled Veteran-Owned Small Business (SDVOSB) Set-Aside opportunity is for the Albany Stratton VA Medical Center in Albany, NY, to replace end-of-life equipment. Offers are due by March 26, 2026, at 10:00 AM EDT.

Scope of Work

This acquisition is for one (1) Medrad® Stellant® Flex® OCS CT Injection System, which must be a brand-name-only product. Key requirements include:

  • Brand Name: Medrad® Stellant® Flex® OCS CT Injection System.
  • Capability: Must feature DualFlow capability.
  • Compatibility: Must be compatible with existing syringe kits used at Albany VAMC, specifically FLEXS-150-SPK, FLEXD-150-SPK, FLEXS-200-SPK, FLEXD-200-SPK, FLEXS-150-QFT, FLEXD-150-QFT, FLEXS-200-QFT, FLEXD-200-QFT, FLEXD-150-SCS, and FLEXD-200-SCS.
  • Deliverable: Includes the supply and installation of an Overhead Counterpoise System. A trade-in credit for the previous system is also part of this transaction.

Contract Details

  • Contract Type: Firm-Fixed-Price.
  • Set-Aside: Service-Disabled Veteran-Owned Small Business (SDVOSB) Set-Aside (FAR 19.14).
  • NAICS Code: 334517 (In Vitro Diagnostic Apparatus Manufacturing).
  • Size Standard: 1200 Employees.
  • Place of Performance: Albany Stratton VA Medical Center, Albany, NY 12208.

Submission & Evaluation

  • Offer Due Date: March 26, 2026, 10:00 AM EDT.
  • Submission Instructions: Offers must be submitted to the issuing office. Specific instructions are detailed in Section E of the solicitation. Offerors must complete and submit representations and certifications electronically via SAM or as specified.
  • Evaluation Criteria: While not explicitly detailed, evaluation will likely consider price and technical compliance with the brand-name-only requirements.

Contact Information

People

Points of Contact

Morgan S WeeksPRIMARY

Files

Files

Download

Versions

Version 1Viewing
Combined Synopsis/Solicitation
Posted: Mar 20, 2026
Medrad Stellant CT Injection System | GovScope